Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner
Kidney International · 2025
DOI: 10.1016/j.kint.2024.10.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Maryam Amini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biophysics, Saarland University, Homburg, Germany. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Interleukin-1alpha, Renal Insufficiency, Chronic, Reactive Oxygen Species. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universität des Saarlandes.
Abstract (Originalsprache)
Onset, progression and cardiovascular outcome of chronic kidney disease (CKD) are influenced by the concomitant sterile inflammation. The pro-inflammatory cytokine family interleukin (IL)-1 is crucial in CKD with the key alarmin IL-1α playing an additional role as an adhesion molecule that facilitates immune cell tissue infiltration and consequently inflammation. Here, we investigate calcium ion and reactive oxygen species (ROS)-dependent regulation of different aspects of IL-1α-mediated inflammation. We show that human CKD monocytes exhibit altered purinergic calcium ion signatures. Monocyte IL-1α release was reduced when inhibiting P2X7, and to a lesser extent P2X4, two ATP-receptors that were found upregulated compared to monocytes from healthy people. In murine CKD models, deleting P2X7 (P2X7-/-) abolished IL-1α release but increased IL-1α surface presentation by bone marrow derived macrophages and impaired immune cell infiltration of the kidney without protecting kidney function. In contrast, immune cell infiltration into injured wild type and P2X7-/- hearts was comparable in a myocardial infarction model, independent of previous kidney injury. Both the chimeric mouse line harboring P2X7-/- immune cells in wild type recipient mice, and the inversely designed chimeric line showed less acute inflammation. However, only the chimera harboring P2X7-/- immune cells showed a striking resistance against injury-induced cardiac remodeling. Mechanistically, ROS measurements reveal P2X7-induced mitochondrial ROS as an essential factor for IL-1α release by monocytes. Our studies uncover a dual role of P2X7 in regulating IL-1α biogenesis with consequences for inflammation and inflammation-induced deleterious cardiac remodeling that may determine clinical outcomes in CKD therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biophysics, Saarland University, Homburg, Germany.
- Institute of Biophysics, Saarland University, Homburg, Germany; Center of Human and Molecular Biology (ZHMB), Saarland University, Homburg, Germany; Center for Gender-Specific Biology and Medicine (CGBM), Saarland Unive…
- Department of Internal Medicine 4, Nephrology, Goethe University Frankfurt, Frankfurt, Germany; Goethe University Frankfurt, Else Kröner Fresenius Center for Nephrological Research, Frankfurt, Germany.
- Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland University, Homburg, Germany.
- Department of Internal Medicine IV, Nephrology and Hypertension, Saarland University, Homburg, Germany.
- Institute of Biophysics, Saarland University, Homburg, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Universität des Saarlandes
Zitieren
APA
Amini, M., Frisch, J., Jost, P., Sarakpi, T., Selejan, S. R., Becker, E., Sellier, A., Engel, J., Böhm, M., Hohl, M., Noels, H., Maack, C., Schunk, S., Roma, L. P., Niemeyer, B. A., Speer, T., & Alansary, D. (2025). Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner. Kidney International. https://doi.org/10.1016/j.kint.2024.10.024
Vancouver
Amini M, Frisch J, Jost P, Sarakpi T, Selejan SR, Becker E, et al. Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner. Kidney International. 2025. doi:10.1016/j.kint.2024.10.024
BibTeX
@article{Amini2025,
author = {Amini, Maryam and Frisch, Janina and Jost, Priska and Sarakpi, Tamim and Selejan, Simina-Ramona and Becker, Ellen and Sellier, Alexander and Engel, Jutta and Böhm, Michael and Hohl, Mathias and Noels, Heidi and Maack, Christoph and Schunk, Stefan and Roma, Leticia Prates and Niemeyer, Barbara A and Speer, Thimoteus and Alansary, Dalia},
title = {Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner},
journal = {Kidney International},
year = {2025},
doi = {10.1016/j.kint.2024.10.024}
}
EUVIMED